Diligence memo · auto-generated · as of July 2, 2026

CodaMetrix Inc.

CodaMetrix Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

CodaMetrix Inc. operates in Other Health Care, based in BOSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

CodaMetrix Inc. has raised $106M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $57M on 2022-12-16.

Most recent recorded round closed around 2025-04-16.

Valuation (modeled)modeled

Provath models CodaMetrix Inc. at approximately $78M (range $42M–$106M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.34× the median modeled value of Series C Other Health Care companies in 2025–2027 (20 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 14 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 3.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Other Health Care peers (5376 compared).

Modeled value ranks above 74% of those peers.

Closest niche peers: RESTOR3D, Inc., ByHeart, Inc., SpyGlassPharma, Inc., VantAI Holdings, Inc., BioIntelliSense, Inc..

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.